...
首页> 外文期刊>Clinical Rheumatology >Osteonecrosis of the femoral head in patients with type 1 human immunodeficiency virus infection: clinical analysis and review
【24h】

Osteonecrosis of the femoral head in patients with type 1 human immunodeficiency virus infection: clinical analysis and review

机译:1型人类免疫缺陷病毒感染患者股骨头骨坏死的临床分析与评论

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Osteonecrosis of the femoral head (ONFH) typically affects relatively young, active patients and frequently follows an unrelenting course resulting in considerable loss of function. In human immunodeficiency virus-infected patients, ONFH is a growing problem. Etiology, pathogenesis, and treatment of ONFH in these patients remain controversial. We analyzed retrospectively patients with ONFH in a series of 815 patients followed in our AIDS reference center. Six patients out of the 815 were affected by ONFH (0.74%). The sex ratio was 1. Two of the six patients (33.3%) had no evidence of risk factor, whereas four patients (66.6%) had risk factors. One patient had three cumulated risk factors which were corticosteroids, chemotherapy, and radiotherapy. For this patient, the onset time for ONFH was shorter (36 months). It is difficult to attribute the effect to any single class of antiretroviral agents because combination therapy is standard of care, and a change in therapies is common. All classes of antiretroviral drugs have been used: protease inhibitors (mean use duration of 15.2 months before the ONFH onset), non-nucleoside reverse transcriptase inhibitors (12 months), and nucleoside reverse transcriptase inhibitors (40.5 months). ONFH was bilateral in four cases (66.6%) and unilateral in two cases (33.3%). One patient had other osteonecrosis location (both shoulders). ONFH was classified on plain radiography stage IV in five patients and stage III in one patient. All patients received initial medical treatment. It consisted of painkillers and non-weight bearing of the hip. All were finally operated on by total hip arthroplasty (THA). The average interval between ONFH diagnosis and the first THA was 10.3 months for the six patients. A controlateral THA was performed for three patients after a mean interval of 23.3 months after ONFH diagnosis. Of the nine implanted prostheses, four were cemented, four were cementless, and one was resurfacing prosthesis.
机译:股骨头坏死(ONFH)通常会影响相对年轻,活跃的患者,并经常遵循不懈的过程,导致功能严重丧失。在人类免疫缺陷病毒感染的患者中,ONFH是一个日益严重的问题。这些患者的ONFH的病因,发病机制和治疗仍存在争议。在我们的艾滋病参考中心,我们对815例患者中的ONFH患者进行了回顾性分析。 815名患者中有6名患者受到ONFH的影响(0.74%)。性别比为1。6名患者中有2名(33.3%)没有危险因素的证据,而4名患者(66.6%)有危险因素。一名患者有三个累积的危险因素,即皮质类固醇,化学疗法和放射疗法。对于该患者,ONFH的发作时间较短(36个月)。很难将这种作用归因于任何一类抗逆转录病毒药物,因为联合治疗是护理的标准,并且治疗方法的改变是常见的。已经使用了所有类型的抗逆转录病毒药物:蛋白酶抑制剂(ONFH发作前平均使用时间为15.2个月),非核苷类逆转录酶抑制剂(12个月)和核苷类逆转录酶抑制剂(40.5个月)。 ONFH为双侧4例(66.6%),单侧2例(33.3%)。一名患者有其他骨坏死部位(双肩)。 ONFH在5例患者的X线平片上被分类为1例患者,在III期上被分类。所有患者均接受了初始药物治疗。它由止痛药和不承重髋关节组成。最终所有手术均通过全髋关节置换术(THA)进行。 6例患者从ONFH诊断到首次THA的平均间隔为10.3个月。在ONFH诊断后平均间隔23.3个月后,对三名患者进行了对照THA。在9个植入的假体中,有4个是胶合的,有4个是非胶合的,其中1个是表面修复的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号